Shelley sent me this link to Christopher Alkenbrack's response to Yves Savoie regarding the MS Society's press release concerning their Board reserving MSSC funds for CCSVI clinical trials when the research allows them to do so. It's interesting reading: http://www.facebook.com/topic.php?uid=110317832313822&topic=448
Subscribe to:
Post Comments (Atom)
Posts
No comments:
Post a Comment